Search Results - "Polizzotto, Mark N."

Kaposi Sarcoma–Associated Herpesvirus-Associated Malignancies: Epidemiology, Pathogenesis, and Advances in Treatment by Bhutani, Manisha, Polizzotto, Mark N, Uldrick, Thomas S, Yarchoan, Robert

“…Kaposi sarcoma associated herpesvirus (KSHV), a γ2-herpesvirus, also known as human herpesvirus-8, is the etiologic agent of three virally associated tumors:…”
Get full text

Viral, immunologic, and clinical features of primary effusion lymphoma by Lurain, Kathryn, Polizzotto, Mark N., Aleman, Karen, Bhutani, Manisha, Wyvill, Kathleen M., Gonçalves, Priscila H., Ramaswami, Ramya, Marshall, Vickie Ann, Miley, Wendell, Steinberg, Seth M., Little, Richard F., Wilson, Wyndham, Filie, Armando C., Pittaluga, Stefania, Jaffe, Elaine S., Whitby, Denise, Yarchoan, Robert, Uldrick, Thomas S.

“…Primary effusion lymphoma (PEL) is an aggressive HIV-associated lymphoma with a relatively poor prognosis in the era of effective HIV therapy. Kaposi sarcoma…”
Get full text

Prevalence and incidence of hypertension in a heavily treatment-experienced cohort of people living with HIV in Uganda by Byonanebye, Dathan M, Polizzotto, Mark N, Parkes-Ratanshi, Rosalind, Musaazi, Joseph, Petoumenos, Kathy, Castelnuovo, Barbara

“…The effect of long-term exposure to antiretroviral therapy (ART) on hypertension in sub-Saharan Africa remains unclear. We aimed to determine the prevalence…”
Get full text

Monoclonal antibody levels and protection from COVID-19 by Stadler, Eva, Burgess, Martin T., Schlub, Timothy E., Khan, Shanchita R., Chai, Khai Li, McQuilten, Zoe K., Wood, Erica M., Polizzotto, Mark N., Kent, Stephen J., Cromer, Deborah, Davenport, Miles P., Khoury, David S.

“…Multiple monoclonal antibodies have been shown to be effective for both prophylaxis and therapy for SARS-CoV-2 infection. Here we aggregate data from…”
Get full text

Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV-MCD) and the KSHV Inflammatory Cytokine Syndrome by Polizzotto, Mark N, Uldrick, Thomas S, Hu, Duosha, Yarchoan, Robert

“…Soon after the discovery of Kaposi sarcoma (KS)-associated herpesvirus (KSHV), it was appreciated that this virus was associated with most cases of…”
Get full text

Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease by Polizzotto, Mark N., Uldrick, Thomas S., Wang, Victoria, Aleman, Karen, Wyvill, Kathleen M., Marshall, Vickie, Pittaluga, Stefania, O'Mahony, Deirdre, Whitby, Denise, Tosato, Giovanna, Steinberg, Seth M., Little, Richard F., Yarchoan, Robert

“…Kaposi sarcoma herpesvirus (KSHV)-associated multicentric Castleman disease (MCD) is a polyclonal B-cell lymphoproliferative disorder. Human (h) IL-6 and a…”
Get full text

Outcomes of human immunodeficiency virus‐associated Burkitt lymphoma and diffuse large B‐cell lymphoma treated in Australia: A report from the Australasian Lymphoma Alliance by Lim, Kenneth J. C., Di Ciaccio, Pietro, Polizzotto, Mark N., Milliken, Sam, Cochrane, Tara, Goh, Zhong, Shaw, Briony, Perry, Evelyn, Gilbertson, Michael, Kermode, William, Cheah, Chan Y., Latimer, Maya, Hamad, Nada, Ku, Matthew

“…Summary Antiretroviral therapy (ART) has improved outcomes for human immunodeficiency virus‐associated non‐Hodgkin lymphoma (HIV‐NHL). This is an analysis of…”
Get full text

Kaposi Sarcoma Herpesvirus Promotes Endothelial-to-Mesenchymal Transition through Notch-Dependent Signaling by GASPERINI, Paola, ESPIGOL-FRIGOLE, Georgina, MCCORMICK, Peter J, SALVUCCI, Ombretta, MARIC, Dragan, ULDRICK, Thomas S, POLIZZOTTO, Mark N, YARCHOAN, Robert, TOSATO, Giovanna

“…Endothelial-to-mesenchymal transition (EndMT) is now widely considered a pivotal contributor to cancer progression. In this study, we show that the Kaposi's…”
Get full text

Sequencing of Kaposi's Sarcoma Herpesvirus (KSHV) genomes from persons of diverse ethnicities and provenances with KSHV-associated diseases demonstrate multiple infections, novel polymorphisms, and low intra-host variance by Marshall, Vickie A, Cornejo Castro, Elena M, Goodman, Charles A, Labo, Nazzarena, Liu, Isabella, Fisher, Nicholas C, Moore, Kyle N, Nair, Ananthakrishnan, Immonen, Taina, Keele, Brandon F, Polizzotto, Mark N, Uldrick, Thomas S, Mu, Yunxiang, Saswat, Tanuja, Krug, Laurie T, McBride, Kevin M, Lurain, Kathryn, Ramaswami, Ramya, Yarchoan, Robert, Whitby, Denise

“…Recently published near full-length KSHV genomes from a Cameroon Kaposi sarcoma case-control study showed strong evidence of viral recombination and mixed…”
Get full text

High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy by Uldrick, Thomas S., Polizzotto, Mark N., Aleman, Karen, O'Mahony, Deirdre, Wyvill, Kathleen M., Wang, Victoria, Marshall, Vickie, Pittaluga, Stefania, Steinberg, Seth M., Tosato, Giovanna, Whitby, Denise, Little, Richard F., Yarchoan, Robert

“…Kaposi sarcoma herpesvirus (KSHV)–associated multicentric Castleman disease (MCD) is a lymphoproliferative disorder most commonly observed in HIV-infected…”
Get full text

Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, Australia by Dharan, Nila J, Sasson, Sarah C, Ahlenstiel, Golo, Andersen, Christopher R, Bloch, Mark, Buckland, Griselda, Hamad, Nada, Han, Win Min, Kelleher, Anthony D, Long, Georgina V, Matthews, Gail V, Mina, Michael M, Papot, Emmanuelle, Petoumenos, Kathy, Swaminathan, Sanjay, Withers, Barbara, Yun, James, Polizzotto, Mark N

“…People with immunocompromising conditions are at increased risk of SARS-CoV-2 infection and mortality, however early in the pandemic it was challenging to…”
Get full text

Phase II Study of Bevacizumab in Patients With HIV-Associated Kaposi's Sarcoma Receiving Antiretroviral Therapy by ULDRICK, Thomas S, WYVILL, Kathleen M, WHITBY, Denise, LITTLE, Richard F, YARCHOAN, Robert, KUMAR, Pallavi, O'MAHONY, Deirdre, BERNSTEIN, Wendy, ALEMAN, Karen, POLIZZOTTO, Mark N, STEINBERG, Seth M, PITTALUGA, Stefania, MARSHALL, Vickie

“…Alternatives to cytotoxic agents are desirable for patients with HIV-associated Kaposi's sarcoma (KS). Vascular endothelial growth factor-A (VEGF-A)…”
Get full text

Heterogeneity and breadth of host antibody response to KSHV infection demonstrated by systematic analysis of the KSHV proteome by Labo, Nazzarena, Miley, Wendell, Marshall, Vickie, Gillette, William, Esposito, Dominic, Bess, Matthew, Turano, Alexandra, Uldrick, Thomas, Polizzotto, Mark N, Wyvill, Kathleen M, Bagni, Rachel, Yarchoan, Robert, Whitby, Denise

“…The Kaposi sarcoma associated herpesvirus (KSHV) genome encodes more than 85 open reading frames (ORFs). Serological evaluation of KSHV infection now generally…”
Get full text

Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interleukin-6 by X-Box Binding Protein 1 by Hu, Duosha, Wang, Victoria, Yang, Min, Abdullah, Shahed, Davis, David A, Uldrick, Thomas S, Polizzotto, Mark N, Veeranna, Ravindra P, Pittaluga, Stefania, Tosato, Giovanna, Yarchoan, Robert

“…Kaposi's sarcoma-associated herpesvirus (KSHV) is the causative agent for Kaposi sarcoma (KS), primary effusion lymphoma (PEL), and a subset of multicentric…”
Get full text

The Health Gym: synthetic health-related datasets for the development of reinforcement learning algorithms by Kuo, Nicholas I-Hsien, Polizzotto, Mark N., Finfer, Simon, Garcia, Federico, Sönnerborg, Anders, Zazzi, Maurizio, Böhm, Michael, Kaiser, Rolf, Jorm, Louisa, Barbieri, Sebastiano

“…In recent years, the machine learning research community has benefited tremendously from the availability of openly accessible benchmark datasets. Clinical…”
Get full text

HIV treatment regimens and adherence to national guidelines in Australia: an analysis of dispensing data from the Australian pharmaceutical benefits scheme by Dharan, Nila J, Radovich, Tomas, Che, Samuel, Petoumenos, Kathy, Juneja, Prabhjot, Law, Matthew, Huang, Robin, McManus, Hamish, Polizzotto, Mark N, Guy, Rebecca, Cronin, Peter, Cooper, David A, Gray, Richard T

“…Treatment guidelines for antiretroviral therapy (ART) have evolved to emphasize newer regimens that address ageing-related comorbidities. Using national…”
Get full text

Deconstructing the liquid architecture of human herpesvirus 8 diseases by Polizzotto, Mark N.

“…Human herpesvirus 8 (HHV‐8), also called Kaposi sarcoma herspesvirus (KSHV), causes several human tumours, which may be associated with systemic inflammation…”
Get full text

Corrigendum: Clinical manifestations of Kaposi sarcoma herpesvirus lytic activation: multicentric Castleman disease (KSHV-MCD) and the KSHV inflammatory cytokine syndrome by Polizzotto, Mark N, Uldrick, Thomas S, Hu, Duosha, Yarchoan, Robert

“…[This corrects the article on p. 73 in vol. 3, PMID: 22403576.]…”
Get full text

Human herpes virus 8-related illness: still with us by Woolley, Ian, Boix, Vicente, Polizzotto, Mark N.

Get full text

Bisphosphonate‐associated osteonecrosis of the auditory canal by Polizzotto, Mark N., Cousins, Vincent, Schwarer, Anthony P.

Get full text